Search images on Google Product Monograph
Active Ingredients:
- ravulizumab, 300 MG/3 ML
DIN: 02533448
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: ALEXION PHARMA GMBH
ATC:
- L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
- L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
- L04AJ - (ATC, WHO)
- L04AJ02 - RAVULIZUMAB (WHO)